{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:52:06Z","timestamp":1793411526185,"version":"4.5.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Team Westland","id":[{"id":"https:\/\/ror.org\/03t8qvt86","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We aimed to evaluate the preferred and received end-of-life (EoL) care in glioblastoma patients who participated in a local nurse-led advance care planning (ACP) program, as well as the perceived quality of care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Twelve proxies of patients with glioblastoma who participated in an ACP program completed a study-specific questionnaire after the patient deceased, comprising the following topics: organization of EoL care, patient\u2019s preferences and wishes, received care during the last 3 months, and proxies\u2019 experiences with EoL care. The outcomes were compared with those from a historical cohort of Dutch patients with glioblastoma (n\u2005=\u200571) who did not receive ACP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nine out of 12 patients lived at home 3 months before death and most (8\/12) died at home. In 11\/12 cases, the general practitioner was responsible for EoL care in the last week before death. Proxies indicated that most patients rated their quality of received EoL care as very good to excellent in the last 3 months and last week before death (67% and 75%, respectively), that 8\/12 patients died with dignity and that all proxies were involved as much as they wanted in decision-making. One-third of the patients in the ACP cohort were relocated at least once in the last 3 months versus 48% of the patients in the historical cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite the limited number of participants, this study suggests that a nurse-led ACP program has a positive impact on several aspects of EoL care for patients with glioblastoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/nop\/npaf050","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T09:08:27Z","timestamp":1747818507000},"page":"821-829","source":"Crossref","is-referenced-by-count":7,"title":["End-of-life care in patients with glioblastoma after early advance care planning"],"prefix":"10.1093","volume":"12","author":[{"given":"Lara","family":"Fritz","sequence":"first","affiliation":[{"name":"Department of Neurology, Haaglanden Medical Center , The Hague ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Zaloumis","sequence":"additional","affiliation":[{"name":"Department of Neurology, Leiden University Medical Center , Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke","family":"Zwinkels","sequence":"additional","affiliation":[{"name":"Department of Neurology, Haaglanden Medical Center , The Hague ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap C","family":"Reijneveld","sequence":"additional","affiliation":[{"name":"Department of Neurology, Stichting Epilepsie Instellingen Nederland (SEIN) , Heemstede ,","place":["The Netherlands"]},{"name":"Department of Neurology and Brain Tumor Center Amsterdam, Amsterdam University Medical Centers, VU University Medical Center , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike J","family":"Vos","sequence":"additional","affiliation":[{"name":"Department of Neurology, Leiden University Medical Center , Leiden ,","place":["The Netherlands"]},{"name":"Department of Neurology, Haaglanden Medical Center , The Hague ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H Roeline W","family":"Pasman","sequence":"additional","affiliation":[{"name":"Department of Public and Occupational Health,Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Expertise Center for Palliative Care Amsterdam , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9157-9895","authenticated-orcid":false,"given":"Linda","family":"Dirven","sequence":"additional","affiliation":[{"name":"Department of Neurology, Leiden University Medical Center , Leiden ,","place":["The Netherlands"]},{"name":"Department of Neurology, Haaglanden Medical Center , The Hague ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3648-9616","authenticated-orcid":false,"given":"Johan A F","family":"Koekkoek","sequence":"additional","affiliation":[{"name":"Department of Neurology, Leiden University Medical Center , Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J B","family":"Taphoorn","sequence":"additional","affiliation":[{"name":"Department of Neurology, Leiden University Medical Center , Leiden ,","place":["The Netherlands"]},{"name":"Department of Neurology, Haaglanden Medical Center , The Hague ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"issue":"10","key":"2025100904421654400_CIT0001","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1158\/1055-9965.EPI-14-0275","article-title":"Epidemiologic and molecular prognostic review of glioblastoma","volume":"23","author":"Thakkar","year":"2014","journal-title":"Cancer Epidemiol Biomark Prev."},{"issue":"13","key":"2025100904421654400_CIT0002","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.ejca.2014.05.019","article-title":"Changing incidence and improved survival of gliomas","volume":"50","author":"Ho","year":"2014","journal-title":"Eur J Cancer."},{"issue":"10","key":"2025100904421654400_CIT0003","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med."},{"issue":"9354","key":"2025100904421654400_CIT0004","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0140-6736(03)12328-8","article-title":"Primary brain tumours in adults","volume":"361","author":"Behin","year":"2003","journal-title":"Lancet."},{"issue":"1","key":"2025100904421654400_CIT0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11060-008-9670-x","article-title":"End of life issues in brain tumor patients","volume":"91","author":"Pace","year":"2009","journal-title":"J Neurooncol."},{"issue":"11","key":"2025100904421654400_CIT0006","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/neuonc\/nop045","article-title":"Symptoms and problems in the end-of-life phase of high-grade glioma patients","volume":"12","author":"Sizoo","year":"2010","journal-title":"Neuro-Oncol."},{"issue":"6","key":"2025100904421654400_CIT0007","first-page":"733","article-title":"Prospective assessment of end-of-life symptoms and quality of life in patients with high-grade glioma","volume":"11","author":"Walbert","year":"2024","journal-title":"Neurooncol Pract."},{"issue":"6","key":"2025100904421654400_CIT0008","first-page":"599","article-title":"Determining medical decision-making capacity in brain tumor patients: why and how","volume":"7","author":"Pace","year":"2020","journal-title":"Neurooncol Pract."},{"issue":"3","key":"2025100904421654400_CIT0009","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/bmjspcare-2015-000886","article-title":"The diverse impact of advance care planning: a long-term follow-up study on patients\u2019 and relatives\u2019 experiences","volume":"7","author":"Andreassen","year":"2017","journal-title":"BMJ Support Palliat Care."},{"issue":"1","key":"2025100904421654400_CIT0010","first-page":"3","article-title":"Integration of palliative care into the neuro-oncology practice: patterns in the United States","volume":"1","author":"Walbert","year":"2014","journal-title":"Neurooncol Pract."},{"issue":"3","key":"2025100904421654400_CIT0011","first-page":"1315","article-title":"Advance care planning in glioblastoma patients: development of a disease-specific ACP program","volume":"28","author":"Fritz","year":"2020","journal-title":"Support Care Cancer."},{"issue":"6","key":"2025100904421654400_CIT0012","first-page":"496","article-title":"Advance care planning (ACP) in glioblastoma patients: evaluation of a disease-specific ACP program and impact on outcomes","volume":"9","author":"Fritz","year":"2022","journal-title":"Neurooncol Pract."},{"issue":"2","key":"2025100904421654400_CIT0013","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11060-014-1548-5","article-title":"End of life care in high-grade glioma patients in three European countries: a comparative study","volume":"120","author":"Koekkoek","year":"2014","journal-title":"J Neurooncol."},{"issue":"2","key":"2025100904421654400_CIT0014","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1634\/theoncologist.2012-0247","article-title":"The end-of-life phase of high-grade glioma patients: dying with dignity","volume":"18","author":"Sizoo","year":"2013","journal-title":"Oncologist."},{"issue":"2","key":"2025100904421654400_CIT0015","first-page":"84","article-title":"Dying, dignity, and new horizons in palliative end-of-life care 1","volume":"56","author":"Chochinov","year":"2006","journal-title":"CA Cancer J Clin."},{"issue":"9","key":"2025100904421654400_CIT0016","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/S1470-2045(17)30582-X","article-title":"Definition and recommendations for advance care planning: an international consensus supported by the European Association for Palliative Care","volume":"18","author":"Rietjens","year":"2017","journal-title":"Lancet Oncol."},{"issue":"6","key":"2025100904421654400_CIT0017","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/eurpub\/ckn084","article-title":"A comparison of physicians\u2019 end-of-life decision making for non-western migrants and Dutch natives in the Netherlands","volume":"18","author":"Buiting","year":"2008","journal-title":"Eur J Public Health."},{"key":"2025100904421654400_CIT0018","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4324\/9781003074984-29","article-title":"Culture and end of life care: a scoping exercise in seven European countries","volume-title":"The Ethical Challenges of Emerging Medical Technologies. Routledge EBooks, Informa","author":"Gysels","year":"2020"},{"issue":"3","key":"2025100904421654400_CIT0019","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.critrevonc.2011.06.002","article-title":"End-of-life care across Southern Europe: a critical review of cultural similarities and differences between Italy, Spain and Portugal","volume":"82","author":"Menaca","year":"2012","journal-title":"Crit Rev Oncol Hematol."},{"issue":"19","key":"2025100904421654400_CIT0020","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1056\/NEJMsa071143","article-title":"End-of-life practices in the Netherlands under the Euthanasia Act","volume":"356","author":"Van der Heide","year":"2007","journal-title":"N Engl J Med."}],"container-title":["Neuro-Oncology Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/nop\/advance-article-pdf\/doi\/10.1093\/nop\/npaf050\/63295693\/npaf050.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/nop\/article-pdf\/12\/5\/821\/63295693\/npaf050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/nop\/article-pdf\/12\/5\/821\/63295693\/npaf050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:43:15Z","timestamp":1759999395000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nop\/article\/12\/5\/821\/8140772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":20,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,22]]},"published-print":{"date-parts":[[2025,10,9]]}},"URL":"https:\/\/doi.org\/10.1093\/nop\/npaf050","relation":{},"ISSN":["2054-2577","2054-2585"],"issn-type":[{"value":"2054-2577","type":"print"},{"value":"2054-2585","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,5,22]]}}}